Special Edition: Coronavirus Rundown

Mar 17, 2020 | Clinical Summary Series, Digital Media, NASH, Non-Alcoholic Fatty Liver Disease, Popular Posts, Video

Corona Virus

This is a special edition episode to make it easy for you to keep up with our reporting on various clincal trials associated with COVID-19.

  • White House Deal Making Moves into Biotech with Recent Bid to Secure Exclusive Rights to COVID-19 Vaccine from Germany.
  • China has fully Ramped up COVID-19 Clinical Trials While the U.S. is just starting.
  • University of Miami-Originated IP the Basis for Prospective COVID-19 Vaccine.
  • University of Minnesota Designated Regional Treatment Center for COVID-19 Launching Three Clinical Trials.
  • Sanofi Pasteur Collaborates with U.S. HHS on Potential COVID-19 Vaccine that could be Produced at PA Site.
  • INOVIO Receives New $5 Million Grant to Accelerate Scale Up of Smart Delivery Device for Its COVID-19 Vaccine.
  • Nationwide Children’s Hospital Submits Proposal to HHS to use Genetically Engineered NK Cells Targeting COVID-19.
  • Gates Foundation Places $100m into Battling COVID-19 Including University of Leuven Virologist.
  • Gilead Begins Two Phase 3 Trials to Evaluate Remdesivir in Adults Diagnosed with COVID-19 Coronavirus.
  • Kaiser Permanente Washington Conducts COVID-19 Vaccination Clinical Trial.
  • Harbour Biomed Secures $75m to Pursue Coronavirus Vaccine with Mount Sinai.
  • K-State Researchers on Path to Find a Cure for Coronavirus.
  • University of Alabama & Multi-Center Collaboration Help Develop Remdesivir with Gilead Thanks to $37.5m from NIH.
  • University of Nebraska Medical Center to Conduct Clinical Trial Treating Coronavirus.

0 Comments

Pin It on Pinterest